Literature DB >> 35882787

Taurine and Its Anticancer Functions: In Vivo and In Vitro Study.

Ning Ma1,2, Feng He3, Jun Kawanokuchi4,5, Guifeng Wang5, Takenori Yamashita4.   

Abstract

Taurine (2-aminoethanesulfonic acid) is a natural amino acid that is found widely in all mammalian tissues. Several studies have demonstrated that taurine has anti-inflammatory, antioxidant, and hypoglycemic effects. Recently, taurine not only mitigates the side effects of chemotherapy in cancer but also possesses antitumor properties, including inhibiting cancer cell proliferation and inducing apoptosis in certain cancers by differential regulating proapoptotic and antiapoptotic proteins. Antitumor studies of taurine are still in their infancy, and the mechanism of its antitumor effect is not fully understood. In this regard, it is worthwhile to study the antitumor mechanism of taurine, which may provide clues to develop new synthetic therapeutic molecules. In this mini review, we summarize the main effects of taurine that have shown suppressing actions in the initiation and progression of cancers. The underlying molecular mechanism also suggested that taurine can be a potential clinical application in tumor therapy. In addition, with the in-depth study of different biological functions of taurine, we found that many systemic diseases are associated with taurine. In this review, the research progress of taurine's antitumor effect is briefly summarized including the in vivo and in vitro studies in our laboratory.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Anticancer; Azomethane; Ki-67; PTEN; PUMA; Taurine

Mesh:

Substances:

Year:  2022        PMID: 35882787     DOI: 10.1007/978-3-030-93337-1_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  38 in total

1.  Anti-Cancer Mechanisms of Taurine in Human Nasopharyngeal Carcinoma Cells.

Authors:  Feng He; Ning Ma; Kaoru Midorikawa; Yusuke Hiraku; Shinji Oikawa; Yingxi Mo; Zhe Zhang; Kazuhiko Takeuchi; Mariko Murata
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

2.  Antitumor and immune-modulatory efficacy of dual-treatment based on levamisole and/or taurine in Ehrlich ascites carcinoma-bearing mice.

Authors:  Hany M Ibrahim; Faten R Abdel Ghaffar; Ibrahim A El-Elaimy; Mona S Gouida; Heba M Abd El Latif
Journal:  Biomed Pharmacother       Date:  2018-06-23       Impact factor: 6.529

3.  Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients.

Authors:  I M El Agouza; S S Eissa; M M El Houseini; Dalia E El-Nashar; O M Abd El Hameed
Journal:  Angiogenesis       Date:  2011-05-08       Impact factor: 9.596

4.  Taurine attenuates fanconi syndrome induced by ifosfamide without compromising its antitumor activity.

Authors:  O A Badary
Journal:  Oncol Res       Date:  1998       Impact factor: 5.574

5.  Taurine supplementation and pancreatic remodeling.

Authors:  Abdeslem El Idrissi; Latifa Boukarrou; William L'Amoreaux
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 6.  Autophagy and apoptosis dysfunction in neurodegenerative disorders.

Authors:  Saeid Ghavami; Shahla Shojaei; Behzad Yeganeh; Sudharsana R Ande; Jaganmohan R Jangamreddy; Maryam Mehrpour; Jonas Christoffersson; Wiem Chaabane; Adel Rezaei Moghadam; Hessam H Kashani; Mohammad Hashemi; Ali A Owji; Marek J Łos
Journal:  Prog Neurobiol       Date:  2013-11-06       Impact factor: 11.685

7.  Taurine exhibits an apoptosis-inducing effect on human nasopharyngeal carcinoma cells through PTEN/Akt pathways in vitro.

Authors:  Feng He; Ning Ma; Kaoru Midorikawa; Yusuke Hiraku; Shinji Oikawa; Zhe Zhang; Guangwu Huang; Kazuhiko Takeuchi; Mariko Murata
Journal:  Amino Acids       Date:  2018-09-17       Impact factor: 3.520

8.  Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells.

Authors:  David Gaucher; Emilie Arnault; Zoé Husson; Nicolas Froger; Elisabeth Dubus; Pauline Gondouin; Diane Dherbécourt; Julie Degardin; Manuel Simonutti; Stéphane Fouquet; M A Benahmed; K Elbayed; Izzie-Jacques Namer; Pascale Massin; José-Alain Sahel; Serge Picaud
Journal:  Amino Acids       Date:  2012-04-04       Impact factor: 3.520

Review 9.  Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment.

Authors:  Federica Cossu; Mario Milani; Eloise Mastrangelo; Daniele Lecis
Journal:  Comput Struct Biotechnol J       Date:  2019-01-25       Impact factor: 7.271

Review 10.  Apoptosis and molecular targeting therapy in cancer.

Authors:  Mohamed Hassan; Hidemichi Watari; Ali AbuAlmaaty; Yusuke Ohba; Noriaki Sakuragi
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.